CDLXNasdaqServices-Computer Programming, Data Processing, Etc.Fiscal year ends December 31
Cardlytics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$1.84−0.19 (-9.36%)
Close on Oct 19, 2026
- Market cap
- $10.60M
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2015 to 2025
Operating margin
-43.6%−14.8 pts over 5 years
Net margin
-44.4%−14.7 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -16.2% | -7.9% | +4.5% | – |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 39.9% | -36.9% | -326.0% | |
| Return on assets | – | -17.1% | -30.5% | |
| Current ratio | – | 4.74 | 1.75 | |
| Debt to equity | – | 1.11 | – | |
| Net debt to EBITDA | – | 2.59× | – | |
| Interest coverage | – | -16.2× | 9.6× | |
| Capex to revenue | 1.6% | 2.9% | 0.2% | |
| Diluted shares | 0M | 3M | 5M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Cardlytics generated $110.73M from operations and spent $46.99M on capital expenditure, dividends and share buybacks. 15% of that went back into the business.
Generated
$110.73M
Used
$46.99M
Capital expenditure$6.99M15%Dividends$00%Share buybacks$40.00M85%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-44.4%
×Asset turnover0.69×
×Equity multiplier10.69×
=Return on equity, FY2025-326.0%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | -44.4% | 0.69× | 10.69× | -326.0% |
| FY2024 | -68.0% | 0.58× | 4.72× | -184.9% |
| FY2023 | -43.6% | 0.49× | 3.65× | -77.8% |
| FY2022 | -155.8% | 0.31× | 2.17× | -103.1% |
| FY2021 | -48.1% | 0.32× | 1.99× | -30.3% |
| FY2020 | -29.7% | 0.58× | 2.15× | -36.9% |
| FY2019 | -8.1% | 1.11× | 1.94× | -17.6% |
| FY2018 | -35.2% | 1.18× | -1.62× | 67.7% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
5of 7 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero-$103.49M
- Cash generatingOperating cash flow above zero$9.29M
- Return on assets improvedROA up on the prior year-33.0% → -26.4%
- Earnings backed by cashOperating cash flow above net income$9.29M vs -$103.49M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose1.19 → 1.75
- No dilutionShare count did not rise5M → 5M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose0.48 → 0.59